EGFR and cancer: Notably, the EGF–EGFR and PI3K/AKT pathways are important for cell survival and proliferation (Liu et al., 2020; Levantini et al., 2022; Lagunas-Rangel et al., 2023), providing a mechanistic explanation for the antiproliferative effects of statins in cancer cells.